Business
Manganese X Energy Subsidiary and JV Partner PureBiotic Air Provide Virginia State University Results on Biofilm and Pathogens Including COVID -19
Montreal, Quebec--(Newsfile Corp. - March 16, 2021) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC2) (OTC Pink: MNXXF) ("Manganese X" , "MN" or the "Company")
About this update from Manganese X Energy Corp.
[{"type":"text","content":" Montreal, Quebec--(Newsfile Corp. - March 16, 2021) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC2) (OTC Pink: MNXXF) (\"Manganese X\" , \"MN\" or the \"Company\") is pleased to announce that its wholly owned subsidiary, Disruptive Battery Corp. (DBC) in conjunction with its US JV Partner, PureBiotic Air Inc.(PureBiotic), has received positive preliminary results from its ongoing research study with Virginia State University (VSU). The results include the successful production of the biofilm required to advance its research and testing of the PureBiotic HVAC Delivery System for the mitigation of COVID-19 and other contaminants. CEO Martin Kepman stated, \"The Team is pleased with the progress of the production of biofilm on various type surfaces that are found in all types of facilities and homes. This initial step should accelerate the required research and testing to document the ability of specific PureBiotics AIR Mist Solutions to deconstruct and remove these biofilm structures. It will create hostile environments that will reduce the risk of pathogenic bacteria and viruses, including the current pathogen of concern around the world, SARS-CoV-2 virus that is causing the COVID-19 pandemic. It should also be noted that biofilm is calculated by the Centers for Disease Control and Prevention (CDC) to be responsible for some 80% of all infections and it is found on almost all surfaces, including your skin. The company's ultimate goal is to create a product for FDA certification.\" STUDY SUMMARY: This initial portion of the study covers the formation of biofilms on different surface materials, specifically by pathogenic bacteria, as per the protocols formulated by the VSU Research Team in conjunction with JV Partner and head of R&D at PureBiotic, Lino G. Morris. This will meet the specifications required to document the ability to grow the mandatory required biofilm needed on a wide variety of test surfaces. The study will then further document the ability of specific PureBiotics AIR Mist Solutions to deconstruct and remove these biofilm structures down to the bare microscopic level. This means the removal of any protective cover creating hostile environments in order to reduce the risk of pathogenic bacteria and viruses, including the COVID-19 pathogen. Testing data on these formulations for a wide range of Hospital ...